The NSS in hepatic steatosis can eventually result in hepatic insulin resistance, fibrogenesis and inflammation via the activation of C-Jun, the N-terminal kinase and the PKC pathway, thus perpetuating fatty liver. This evidence concerns the gene PRRT2 and fatty liver disease.